Fighting Brain Inflammation in Parkinson’s

Scientists know that inflammation in the brain—called neuroinflammation—plays an important role in Parkinson’s disease. But it’s still unclear how this inflammation happens in different brain areas and how it affects symptoms like movement problems. A New Way to See Inflammation Researchers developed a special brain scan that can “light up” areas of inflammation by targeting a receptor in the brain’s immune cells called P2X7. They tested this in mice with Parkinson’s-like symptoms and in healthy mice for comparison. Testing an Asthma Drug for Parkinson’s The team gave the animals montelukast (a medication commonly used for asthma) and monitored their movement with weekly tests. After treatment, the animals had: Better movement control Lower levels of brain inflammation seen on scans A strong link between reduced inflammation and improved motor skills Interestingly, another type of brain scan used to measure dopamine activity did not show this same connection—suggesting that inflammation might be a more sensitive marker for movement improvement in this case. Why This Matters This study suggests two big possibilities: Targeting brain inflammation could be a promising way to improve movement in Parkinson’s. This new type of brain scan could help researchers track how well treatments are working, especially ones aimed at reducing inflammation. While these results are from an animal model, they open the door to exploring whether existing drugs like montelukast—or new therapies—might one day help people with Parkinson’s by calming harmful brain inflammation.